XENETIC BIOSCIENCES, INC. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
EPS (Diluted)
$-2
Book Value Per Share
$4
Free Cash Flow Per Share
$-1
Revenue Per Share
$2
OCF Per Share
$-1
Return on Equity
-40.0%
Return on Assets
-35.1%
Return on Invested Capital
-33.4%
Debt to Equity
—
Current Ratio
8.32
Quick Ratio
8.32
Asset Turnover
0.39
Days Sales Outstanding
—
Days Payables Outstanding
—
R&D / Revenue
103.0%
SBC / Revenue
2.2%
Capex / Revenue
—
Working Capital
$7M
Net Current Asset Value
$7M
Invested Capital
$7M
OCF / Net Income
0.85
FCF / Net Income
0.85
Accruals Ratio (Sloan)
-4.7%
Net Debt
—
Net Debt / EBITDA
—
Interest Coverage
—
Cash Coverage
—
Capex Coverage
—
Tangible Common Equity
$7M
TCE / Total Assets
88.4%
Goodwill / Total Assets
—
NOPAT
$-2M
Cash ROIC
-34.1%
WC / Revenue
237.9%
Capex / D&A
—
Reinvestment Rate
—
Asset Growth vs Revenue Growth
2.1%
Revenue 5Y CAGR
46.8%
FCF 5Y CAGR
—
Book Value 5Y CAGR
-9.5%
Stock Price (FY-end)
$2
Market Cap
$4M
P/E Ratio
-1.38
P/S Ratio
1.24
P/B Ratio
0.50
P/TB Ratio
0.50
P/OCF Ratio
-1.61
P/FCF Ratio
-1.61
FCF Yield
-61.9%
Shareholder Yield
-1.8%
Shares Variation (YoY)
10.4%
Beta (5Y)
0.89
Cost of Equity
9.0%
Cost of Debt (after tax)
—
WACC
9.0%
ROIC - WACC Spread
-42.4%
52W High
$10
52W Low
$2
Trailing Return 1M
-11.4%
Trailing Return 6M
-44.9%
Trailing Return 1Y
-47.2%
Trailing Return 5Y
-88.7%
F-Score (Piotroski)
3.00
Z-Score (Altman)
-30.91